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Introduction
Technologies for genetic analysis continue their evolution at
an amazing pace, including advances in whole genome se-
quencing, total RNA sequencing and single cell genomics.
Complementary to these, total sequencing and analytical ser-
vices are increasingly becoming commercial with rapid and
high quality service provision. These developments have led
to the full availability of genetic analysis to ever wider re-
search communities and consequent advances in a variety of
research areas, while the fundamentals have not changed: with
all of the novel tools that are becoming available, critical
thinking and alertness shown by well-trained clinicians
working seamlessly together with scientists remain the key
to success.
The technical advances are, furthermore, changing the val-
ue of discovery research and the way that it integrates into the
further development of solutions for direct patient benefit: the
biopharmaceutical and diagnostic industries need to co-
operate with the best producers of discovery data, which usu-
ally come from universities and research institutions. These
developments also call for increasing adherence to quality
standards in genetics, patient data and massive sample repos-
itories with repercussions in legal and commercial issues. We
can fairly state that, in many ways, the traditional research
concepts are at crossroads and must re-adjust. The research
community working on kidney diseases has been early to
adapt and, consequently, has benefitted hugely from the new
technologies and approaches.
In this special issue of Cell and Tissue Research, called
BGenetic Kidney Diseases^, we present the leading edge of
research achievements, novel approaches and prospects for
the future so that we can better anticipate the next level of
research into hereditary and acquired kidney diseases.
Genetics of kidney diseases
Genetic kidney diseases account for a considerable fraction of
end stage renal kidney disease. Novel monogenetic causes,
genetic modifiers and new risk gene variants for kidney dis-
eases have been discovered at an amazing pace in recent years.
This knowledge is currently being translated into a much
deeper understanding of the pathophysiology of many renal
diseases.
In his article BNew structural insights into podocyte biolo-
gy ,̂ Florian Grahammer (2017) highlights the latest advances
in light- and electron-microscopic techniques and shows their
skilful application in revealing the remaining controversies in
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the assembly of key elements composing the glomerular filtra-
tion barrier. Notably, the novel imaging approaches have led to a
new understanding of the way that the congenital nephrosis
gene product NEPHRIN together with NEPH1 forms the slit
diaphragm, an advance that will hopefully translate into a better
understanding of proteinuric diseases.
In his article BRole of primary cilia in non-dividing and
post-mitotic cells^, Gerd Walz (2017) describes yet another
intriguing aspect, namely the role of primary cilia in differen-
tiated post-mitotic cells in the regulation of, for example,
DNA damage responses, autophagy and mitochondrial func-
tions. By integrating these different cellular functions, primary
cilia in non-dividing cells seem to form a signalling hub con-
trolling cell homeostasis.
Apoptosis is a known regulatory process in the develop-
ment of the polycystic diseases in the kidney. In their article
BRole of apoptosis in the development of polycystic kidney
diseases^, Peintner and Borner (2017) summarize key factors
affecting the balance in the polycystin-1- and polycystin-2–
based multiprotein membrane complex and its consequences
for regulating cell survival, proliferation, differentiation and
autophagy in polycystic kidney disease.
The article BInsights into autosomal dominant polycystic
kidney disease by quantitative mass spectrometry-based
proteomics^ by Diedrich and Dengjel (2017) shows the power
of advanced mass-specrometry (MS) methods in revealing the
complex of proteins and their respective associations with
intracellular structures and pathways in autosomal polycystic
kidney disease. More generally, their review shows that the
leading edge technical approach to protein analytics can be of
immense help in understanding disease pathogenesis, protein
modifications and protein-protein interactions in general.
Notably, the prospect of MS-based technologies for disease
diagnostics and monitoring is discussed, paving the way for
their future use as a support in clinical disease management.
Fabry disease is a lysosomal storage disease with often
devastating kidney manifestations. In their article
BPathomechanisms of renal Fabry disease^, Eikrem et al.
(2017) summarize the genetic background and pathophysio-
logic details of this glycosphingolipid disorder. Of note, next
to the enzyme replacement therapy that is used as clinical
routine, novel chaperone-mediated therapies have recently en-
tered the clinical arena. Therefore, Fabry disease represents a
Bmodel disease^ of the way that genetic and pathophysiologic
discovery are providing novel clinical treatment strategies.
Skin and kidney share not only some basic structural mo-
lecular components but also distinct overlapping diseases. In
their review article BRenal-skin syndromes^, Has and He
(2017) provide a comprehensive overview highlighting this
previously underrecognized disease group. Diseases shared
by the skin and the kidney are related to defects in cell-
matrix adhesion and the key molecular players at the shared
sites and experimental models are introduced by these authors.
Furthermore, distinct types of epidermolysis bullosa are
reviewed in depth with a description of their respective renal
involvement.
Mechanisms, consequences and the regulation of the epi-
genetic machinery have rapidly been unfolded, with an in-
creasing understanding of the way that DNA methylation
and histone modifications affect disease progression. In their
article BEpigenetics of kidney disease^, Wanner and Bechtel-
Walz (2017) summarize current knowledge of the renal cell
epigenome in development, maintenance and kidney disease
thereby offering a novel basis for comprehending renal dis-
ease initiation and progression. Furthermore, the promise of
epigenetics for biomarker discovery and emerging new treat-
ments are discussed.
In his article BAdvances in renal genetic diagnosis^,
Bergmann (2017) highlights the benefits that recent technical
advances of next-generation sequencing (NGS) has provided
in disease diagnosis and the identification of the pathophysi-
ology of hereditary nephropathies. The increasing knowledge
of the genotype-phenotype correlation not only provides the
basis for genetic counselling, risk assessment and clinical
management but also offers new therapeutic concepts for sev-
eral genetic diseases.
Disease modeling in genetic kidney diseases
The advances in identifying causal gene mutations or gene
variants associated with kidney diseases offer new opportuni-
ties for basic research and the development of therapeutic
compounds. In recent years, scientists have been creating
models of human genetic disease by using organoids, worms,
flies, zebrafish, frogs, mice and other animals to gain novel
insights into the molecular mechanisms of many renal
diseases.
In their article BGenetic kidney diseases: Caenorhabditis
elegans as model system^, Ganner and Neumann-Haefelin
(2017) review the possibilities of fully utilizing the simple
nematode for studies of disease and developmental aspects
of the kidney. The abundance of genetic similarities between
human species and C. elegans allows the study of slit dia-
phragm biology, ciliopathies, tubulogenesis and general
mechanisms of cellular homeostasis.
Helmstädter and Simons (2017) review the experimental
uses, advantages and limitations of Drosophila in studying
human kidney disease in BUsing Drosophila nephrocytes in
genetic kidney disease^. The high conservation of human
podocyte and proximal tubular cell functions by Drosophila
nephrocytes make them a highly valuable kidney model as
evidenced by recent work. Because of the easy genetic acces-
sibility of Drosophila, this model can be a game changer in
future studies aimed at distinguishing disease-causing se-
quence variants from functional gene variants present in the
human genome.
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Schenk et al. (2017) review the recent advances in
zebrafish models with regard to studying kidney diseases in
BDisease modeling in genetic kidney diseases: zebrafish^. The
major benefits of using zebrafish are the relative simplicity in
inducing genetic manipulations and in monitoring renal func-
tions, even in real time. Recently developed high-throughput
screening and genome editing techniques offer tremendous
opportunities to model kidney diseases in zebrafish.
Getwan and Lienkamp (2017) discuss the implications of
the Xenopus tadpole: BToolbox in a tadpole: Xenopus for kid-
ney research^. With the obvious benefits of the rapid embry-
onic development of Xenopus and the availability of targeted
injections, the tadpole offers obvious benefits for studying, in
particular, organogenesis and genetic diseases. In this article,
the authors review the variety of methods employed so far and
those coming increasingly into use, including those for gene
editing. As the authors point out in the article, the use of the
tadpole system has provided instrumental insight into the mo-
lecular mechanisms of human kidney disease.
For decades, mice with engineered genomes have been
most extensively used for targeted studies of kidney patho-
physiology and genetics. In their article BDisease modeling
in genetic kidney diseases: mice^, Andreas F. Hofmeister
and colleagues (2017) now provide a comprehensive survey
to the methods currently in use and the results obtained for a
better understanding of the biology of the respective disease-
causing genes.
Ganna Reint and coworkers (2017) in their article BKidney
development and perspectives for organ engineering^ provide
intriguing views of alternative developments for future kidney
replacement. In particular, they highlight the emerging tech-
niques of using decellurized and three-dimensional
bioprinting strategies.
In their article BEngineering the kidney: novel approaches
towards reprogramming and directed differentiation of renal
cells^, Kaminski et al. (2017) review the most recently devel-
oped techniques for generating renal cells and tissues by either
directed differentiation or transcription-factor-based
reprogramming. These novel tools offer exciting possibilities
for modeling inherited and acquired kidney diseases from
patient-derived cells, for performing nephrotoxicity testing,
or for potentially developing novel kidney replacement
therapies.
New aspects of cell metabolism, soluble factors,
biomarkers and cell quantification in kidney disease
In recent years, the cell metabolism of renal cells, the soluble
factors mediating glomerular diseases, the previously under-
appreciated cell compartments such as parietal epithelial cells
and novel biomarkers have all entered the center stage of
kidney disease discovery research.
As has been known for a long time, metabolic signaling and
energy metabolism play a critical role in genetic and acquired
kidney disease. In their article BMetabolism and homeostasis in
the kidney: metabolic regulation through insulin signaling in the
kidney ,̂ Kuczkowski and Brinkkoetter (2017) show that the
kidney is not just a passive target of systemic metabolic changes
but that renal cell intrinsic metabolic signaling pathways are
main drivers of renal disease. With the emphasis on insulin
signaling, the authors provide a comprehensive review of the
current understanding and the link between insulin signaling
andmitochondrial function contributing importantly to the path-
ogenesis of kidney disease.
The kidney is either an active participant or an innocent
bystander suffering from collateral damage of immunological
actions. The manner in which the kidney interacts in molecu-
lar terms with other tissues and cross talks with the immuno-
logical system has seen substantial advances in recent years,
especially in the form of circulating factors tentatively identi-
fied in the pathogenesis of idiopathic nephrotic syndrome. In
their review article BExtrarenal determinants of kidney filter
function^, Hahm et al. (2017) provide comprehensive insight
into the derivation of suPAR (from the bone-marrow), its reg-
ulation and its promise not only as a target, but also as a
potential high-value diagnostic biomarker for the management
of this devastating kidney disease.
These ubiquitous vehicles of cell-to-cell communication
and other fundamental biological functions are reviewed by
Barreiro and Holthofer (2017) in their article BUrinary extra-
cellular vesicles. A promising shortcut to novel biomarker
discoveries^. Whereas the re-discovery of these vesicles of
various size categories and overlapping physico-chemical
properties is highlighted by results indicating their value in
changing our understanding of many of the biological path-
ways involved, the lack of standardization results in partially
misleading and overenthusiastic interpretations. Nevertheless,
extracellular vesicles are increasingly relevant for kidney re-
search because of the new and efficient methods of harvesting
them from urine.
Loss of podocytes appears to be the pacemakers of most
progressive kidney diseases. In their article BQuantifying
podocyte depletion: theoretical and practical considerations^,
Victor Puelles and colleagues (2017) provide valuable insights
into podocyte depletion in disease pathogenesis by introduc-
ing currently available methods for quantifying podocyte de-
pletion. These methods include, for example, the analysis of
their number from glomerular cross-sections, stereological
methods and new techniques allowing glomerular analysis in
optically cleared samples. The review provides a balanced
evaluation in all of these techniques suitable for podocyte
quantitation and will be of practical help in the selection of
methods for use.
Whereas glomerular visceral epithelial cells (podocytes)
have long been considered as cornerstones in many
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proteinuric kidney diseases, the role of glomerular parietal
epithelial cells (PECs) of the Bowman’s capsule has remained
enigmatic and controversial. In their review article BParietal
cells-new perspectives in glomerular disease^, Laura Miesen
and coworkers (2017) provide a comprehensive new under-
standing of this cell type. By reviewing the evidence regarding
their important roles as a reservoire for the replacement of lost
podocytes and as the site of extracapillary proliferative lesions
in glomerular disease, their true pathogenetic role becomes
evident. We expect to see future aspects of their role revealed
by the use of targeted experimental models and more accurate
techniques of imaging. Future developments of targeted ther-
apeutics aimed at PECs can also be expected.
We feel that the leading edge researchers with their very
high quality contributions in this special issue provide an ex-
cellent observation point enabling us to see the direction from
which the field has come and the route along which kidney
research and drug development is now heading.
We warmly thank all the contributors for sharing their time,
commitment and special expertise in research-intensive ne-
phrology with our readers. The outcome of this special issue
speaks for itself and we hope that this special issue paves the
way to future discoveries for the benefit of our kidney
patients.
References
Barreiro K, Holthofer H (2017) Urinary extracellular vesicles. A promis-
ing shortcut to novel biomarker discoveries. Cell Tissue Res. doi:10.
1007/s00441-017-2621-0
BergmannC (2017) Advances in renal genetic diagnosis. Cell Tissue Res.
doi:10.1007/s00441-017-2636-6
Diedrich B, Dengjel J (2017) Insights into autosomal dominant polycystic
kidney disease by quantitative mass spectrometry-based proteomics.
Cell Tissue Res. doi:10.1007/s00441-017-2617-9
Eikrem Ø, Skrunes R, Tøndel C, Leh S, Houge G, Svarstad E, Marti HP
(2017) Pathomechanisms of renal Fabry disease. Cell Tissue Res.
doi:10.1007/s00441-017-2609-9
Ganner A, Neumann-Haefelin E (2017) Genetic kidney diseases:
Caenorhabditis elegans as model system. Cell Tissue Res doi:10.
1007/s00441-017-2622-z
Getwan M, Lienkamp SS (2017) Toolbox in a tadpole: Xenopus for
kidney research. Cell Tissue Res. doi:10.1007/s00441-017-2611-2
Grahammer F (2017) New structural insights into podocyte biology. Cell
Tissue Res. doi:10.1007/s00441-017-2590-3
Hahm E, Peev V, Reiser J (2017) Extrarenal determinants of kidney filter
function. Cell Tissue Res. doi:10.1007/s00441-017-2635-7
Has C, He Y (2017) Renal-skin syndromes. Cell Tissue Res. doi:10.1007/
s00441-017-2623-y
Helmstädter M, Simons M (2017) Using Drosophila nephrocytes in ge-
netic kidney disease. Cell Tissue Res. doi:10.1007/s00441-017-
2606-z
Hofmeister AF, Kömhoff M, Weber S, Grgic I (2017) Disease modeling
in genetic kidney diseases: mice. Cell Tissue Res. doi:10.1007/
s00441-017-2639-3
Kaminski MM, Tosic J, Pichler R, Arnold SJ, Lienkamp SS (2017)
Engineering kidney cells: reprogramming and directed differentia-
tion to renal tissues. Cell Tissue Res. doi:10.1007/s00441-017-
2629-5
Kuczkowski A, Brinkkoetter PT (2017) Metabolism and homeostasis in
the kidney: metabolic regulation through insulin signaling in the
kidney. Cell Tissue Res. doi:10.1007/s00441-017-2619-7
Miesen L, Steenbergen E, Smeets B (2017) Parietal cells—new perspec-
tives in glomerular disease. Cell Tissue Res. doi:10.1007/s00441-
017-2600-5
Peintner L, Borner C (2017) Role of apoptosis in the development of
autosomal dominant polycystic kidney disease (ADPKD). Cell
Tissue Res. doi:10.1007/s00441-017-2628-6
Puelles VG, Bertram JF, Moeller MJ (2017) Quantifying podocyte deple-
tion: theoretical and practical considerations. Cell Tissue Res. doi:
10.1007/s00441-017-2630-z
Reint G, Rak-Raszewska A, Vainio SJ (2017) Kidney development and
perspectives for organ engineering. Cell Tissue Res. doi:10.1007/
s00441-017-2616-x
SchenkH,Müller-Deile J, Kinast M, SchifferM (2017)Disease modeling
in genetic kidney diseases: zebrafish. Cell Tissue Res. doi:10.1007/
s00441-017-2593-0
Walz G (2017) Role of primary cilia in non-dividing and post-mitotic
cells. Cell Tissue Res. doi:10.1007/s00441-017-2599-7
Wanner N, Bechtel-Walz W (2017) Epigenetics of kidney disease. Cell
Tissue Res. doi:10.1007/s00441-017-2588-x
4 Cell Tissue Res (2017) 369:1–4
